Biotech NewsRecursion Pharmaceuticals (RXRX) Could Double With $8 Price Target BioTech Health XOctober 3, 2025 Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company that has emerged as one of the pioneers of… 0 Shares 0 0 0 0 0 0 0
